Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wenshen Jianpi Huoxue Lishui Keli is a Traditional Chinese Medicine (TCM) formula presented in granule form. Its name reflects its primary therapeutic principles: 'Wenshen' (warming the kidney), 'Jianpi' (strengthening the spleen), 'Huoxue' (invigorating blood circulation), and 'Lishui' (promoting diuresis or draining dampness). This multi-herb combination is investigated for its potential in various conditions, including irritable bowel syndrome with diarrhea (IBS-D), osteoporosis, and type 2 diabetes mellitus with osteoporosis. Studies suggest its pharmacological effects involve modulating key cellular signaling pathways and influencing processes like inflammation, cell proliferation, and apoptosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wenshen Jianpi Huoxue Lishui Keli.